Exagen Appoints Wendy Johnson to Board of Directors
September 23, 2020 16:10 ET
|
Exagen Inc.
SAN DIEGO, Sept. 23, 2020 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), an organization dedicated to transforming the care continuum for patients suffering from autoimmune diseases, is proud to...
Exagen Launches Test to Aid in the Detection of ANCA-Associated Vasculitis (AAV)
September 21, 2020 08:25 ET
|
Exagen Inc.
SAN DIEGO, Sept. 21, 2020 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), an organization dedicated to transforming the care continuum for patients suffering from autoimmune diseases, today announced...
Exagen to Participate in 2020 Cantor Fitzgerald Virtual Global Healthcare Conference
September 03, 2020 16:05 ET
|
Exagen Inc.
SAN DIEGO, Sept. 03, 2020 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), an organization dedicated to transforming the care continuum for patients suffering from autoimmune diseases, today announced...
Therapeutic Antibody Pioneers Professor Sir Marc Feldmann and Dr. H. Michael Shepard Formally Launch Enosi Life Sciences
September 02, 2020 09:00 ET
|
Enosi Life Sciences
SAN DIEGO, Sept. 02, 2020 (GLOBE NEWSWIRE) -- World-renowned scientists Professor Sir Marc Feldmann and Dr. H. Michael Shepard are pleased to announce the formal launch of Enosi Life Sciences...
Immunoassay Analyzers Market To Reach USD 26.40 Billion By 2027 | Reports and Data
August 27, 2020 17:00 ET
|
Reports and Data
New York, Aug. 27, 2020 (GLOBE NEWSWIRE) -- The Global Immunoassay Analyzers market is forecast to reach USD 26.40 Billion by 2027, according to a new report by Reports and Data. Immunoassay...
Autoimmune Disease Diagnosis Market To Reach USD 7.37 Billion By 2027 | Reports and Data
August 20, 2020 17:00 ET
|
Reports and Data
New York, Aug. 20, 2020 (GLOBE NEWSWIRE) -- The Global Autoimmune Disease Diagnosis Market is forecast to reach USD 7.37 Billion by 2027, according to a new report by Reports and Data. An increase...
Exagen Inc. Announces a Collaboration with Hospital for Special Surgery (HSS) for Antiphospholipid Syndrome
August 03, 2020 16:05 ET
|
Exagen Inc.
SAN DIEGO, Aug. 03, 2020 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), an organization dedicated to transforming the care continuum for patients suffering from autoimmune diseases, announced today...
Exagen to Present at the Canaccord Genuity 40th Annual Growth Conference
July 30, 2020 16:25 ET
|
Exagen Inc.
SAN DIEGO, July 30, 2020 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), an organization dedicated to transforming the care continuum for patients suffering from autoimmune diseases, today announced...
Exagen Inc. Reports Second Quarter 2020 Results
July 28, 2020 07:00 ET
|
Exagen Inc.
Testing Experiencing Monthly Sequential ImprovementRecord Gross Margins of 63% SAN DIEGO, July 28, 2020 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), an organization dedicated to transforming...
Exagen Inc. AVISE Testing Now Covered and In-Network with TRICARE East
July 27, 2020 16:05 ET
|
Exagen Inc.
SAN DIEGO, July 27, 2020 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), an organization dedicated to transforming the care continuum for patients suffering from autoimmune diseases, today announced...